Ascendis Pharma (ASND) PT Lowered to $304 at BofA Securities
Tweet Send to a Friend
BofA Securities analyst Tazeen Ahmad lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $304.00 (from $306.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
